🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the efficacy and safety of adebrelimab consolid...
Status
Recruiting
Location
Henan Cancer Hospital
Start Date
2026-07-17
Trial ID
NCT07559786
Treatments Being Tested
Aim of the trial is to evaluate the activity and tolerability of the anti P...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2022-02-11
Trial ID
NCT04417166
Treatments Being Tested
This study aims to evaluate the efficacy brentuximab vedotin as consolidati...
Status
Completed
Location
CH Victor Dupouy
Start Date
2015-04
Trial ID
NCT02298283
This study is a single-center, single-arm, prospective clinical trial desig...
Status
Recruiting
Location
The Fourth Hospital of Hebei Medical University
Start Date
2025-05-15
Trial ID
NCT06949098
Treatments Being Tested
The purpose of this trial was to evaluate efficacy and safety of adding Rit...
Status
Completed
Location
Az. Ospedaliera SS. Antonio e Biagio e Cesare Arrigo
Start Date
2002-06
Trial ID
NCT00556127
Intensity modulated radiation therapy (IMRT) with or without chemotherapy (...
Status
Completed
Location
Rush University Medical Center
Start Date
2017-01-20
Trial ID
NCT03067610
Treatments Being Tested
Combined modality therapy has then emerged as the standard of care for limi...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-09
Trial ID
NCT00992030
Treatments Being Tested
Many trials that patients with advanced or recurrent indolent lymphoma mana...
Status
Unknown
Location
DiDeng
Start Date
2015-10
Trial ID
NCT02438501
Treatments Being Tested
* Assess responses, progression free survival (PFS) and overall survival (O...
Status
Terminated
Location
National Cancer Centre
Start Date
2011-03
Trial ID
NCT02808091
Treatments Being Tested
The incidence of Hodgkin's lymphoma (HL) in Chinese children and adolescent...
Status
Active Not Recruiting
Location
West China Second University Hospital, Sichuan University, Chengdu, China
Start Date
2018-04-01
Trial ID
NCT04726501
Treatments Being Tested